References
Arulkanthan, A., W.C. Brown, T.C. McGuire, and D.P. Knowles, 1999: Biased immunoglobulin G1 isotype responses induced in cattle with DNA expressing msp1a of Anaplasma marginale. Infect. Immun.67 , 3481–7.
Babiuk, L.A., J. L’Italien, S. van Drunen Littel-van den Hurk, T. Zamb, M.J.P. Lawman, G. Hughes, and G.A. Gifford, 1987: Protection of cattle from bovine herpesvirus type I (BHV-1) infection by immunization with individual viral glycoproteins. Virology 159 , 57–66, DOI: 10.1016/0042-6822(87)90347-3.
Banchereau, J., F. Bazan, D. Blanchard, F. Briè, J.P. Galizzi, C. van Kooten, Y.J. Liu, F. Rousset, and S. Saeland, 1994: The CD40 Antigen and its Ligand Vol. 12Annu. Rev. Immunol.
Bao, Y., X. Liu, C. Han, S. Xu, B. Xie, Q. Zhang, Y. Gu, J. Hou, L. Qian, C. Qian, H. Han, and X. Cao, 2014: Identification of IFN-γ-producing innate B cells. Cell Res. 24 , 161–76, DOI: 10.1038/cr.2013.155.
Bitsch, V., 1973: Infectious bovine rhinotracheitis virus infection in bulls, with special reference to preputial infection. Appl. Microbiol. 26 , 337–43.
Blickenstorfer, S., M. Engels, C. Guerdat, C. Saucy, M. Reist, H. Schwermer, and L. Perler, 2010: [Infectious bovine rhinotracheitis (IBR) in the canton of Jura: an epidemiological outbreak investigation]. Schweiz. Arch. Tierheilkd. 152 , 555–60, DOI: 10.1024/0036-7281/a000124.
Blome, S., C. Gabriel, and M. Beer, 2013: [Possibilities and limitations in veterinary vaccine development using the example of classical swine fever]. Berl. Munch. Tierarztl. Wochenschr.126 , 481–490, DOI: 10.2376/0005-9366-126-41.
Brown, W.C., C.E. Suarez, L.K.M. Shoda, and D.. Estes, 1999: Modulation of host immune responses by protozoal DNA. Vet. Immunol. Immunopathol. 72 , 87–94, DOI: 10.1016/S0165-2427(99)00120-8.
Coutelier, J.P., J.T. van der Logt, and F.W. Heessen, 1991: IgG subclass distribution of primary and secondary immune responses concomitant with viral infection. J. Immunol. 147 , 1383–6.
Deshpande, M.S., T.C. Ambagala, N.R. Hegde, M.J. Hariharan, M. Navaratnam, and S. Srikumaran, 2002: Induction of cytotoxic T-lymphocytes specific for bovine herpesvirus-1 by DNA immunization.Vaccine 20 , 3744–51, DOI: 10.1016/s0264-410x(02)00375-4.
Di Giacomo, S., V. Quattrocchi, and P. Zamorano, 2015: Use of Adjuvants to Enhance the Immune Response Induced by a DNA Vaccine Against Bovine Herpesvirus-1. Viral Immunol. 28 , 343–346, DOI: 10.1089/vim.2014.0113.
Elgueta, R., M.J. Benson, V.C. De Vries, A. Wasiuk, Y. Guo, and R.J. Noelle, 2009 ( May): Molecular mechanism and function of CD40/CD40L engagement in the immune system. Immunol. Rev. 229 , 152–172, DOI: 10.1111/j.1600-065X.2009.00782.x. NIH Public Access.
Estes, D.M., and W.C. Brown, 2002 ( November): Type 1 and type 2 responses in regulation of Ig isotype expression in cattle. Vet. Immunol. Immunopathol. 90 , 1–10, DOI: 10.1016/S0165-2427(02)00201-5.
Estes, D.M., A. Hirano, V.T. Heussler, D.A. Dobbelaere, and W.C. Brown, 1995: Expression and biological activities of bovine interleukin 4: effects of recombinant bovine interleukin 4 on T cell proliferation and B cell differentiation and proliferation in vitro. Cell. Immunol.163 , 268–79, DOI: 10.1006/cimm.1995.1126.
Feinberg, H., R. Castelli, K. Drickamer, P.H. Seeberger, and W.I. Weis, 2007: Multiple modes of binding enhance the affinity of DC-SIGN for high mannose N-linked glycans found on viral glycoproteins. J. Biol. Chem. 282 , 4202–4209, DOI: 10.1074/jbc.M609689200.
Fredriksen, B.N., and J. Grip, 2012: PLGA/PLA micro- and nanoparticle formulations serve as antigen depots and induce elevated humoral responses after immunization of Atlantic salmon (Salmo salar L.).Vaccine 30 , 656–67, DOI: 10.1016/j.vaccine.2011.10.105.
Fuller, A.O., and W.C. Lee, 1992: Herpes simplex virus type 1 entry through a cascade of virus-cell interactions requires different roles of gD and gH in penetration. J. Virol. 66 , 5002–5012, DOI: 10.1128/jvi.66.8.5002-5012.1992.
Gregoriadis, G., A. Bacon, W. Caparros-Wanderley, and B. McCormack, 2002 (20. December): A role for liposomes in genetic vaccination.Vaccine 20 , B1–B9, DOI: 10.1016/S0264-410X(02)00514-5. Elsevier BV.
Hope, J.C., C.J. Howard, H. Prentice, and B. Charleston, 2006: Isolation and purification of afferent lymph dendritic cells that drain the skin of cattle. Nat. Protoc. 1 , 982–7, DOI: 10.1038/nprot.2006.125.
Huang, Y., L.A. Babiuk, and S. van Drunen Littel-van den Hurk, 2005: Immunization with a bovine herpesvirus 1 glycoprotein B DNA vaccine induces cytotoxic T-lymphocyte responses in mice and cattle. J. Gen. Virol. 86 , 887–898, DOI: 10.1099/vir.0.80533-0.
Ip, W.-K., and Y.-L. Lau, 2004: Distinct Maturation of, but Not Migration between, Human Monocyte-Derived Dendritic Cells upon Ingestion of Apoptotic Cells of Early or Late Phases. J. Immunol.173 , 189–196, DOI: 10.4049/jimmunol.173.1.189.
Jones, C., 2003 ( January): Herpes simplex virus type 1 and bovine herpesvirus 1 latency. Clin. Microbiol. Rev. 16 , 79–95, DOI: 10.1128/CMR.16.1.79-95.2003. Clin Microbiol Rev.
Kanthesh, M., N. Loide, N. Raghu, T.S. Gopenath, G.K. Chandrashekrappa, K. Murugesan, G. Ashok, and K. Gobianand, 2018: DNA Vaccines.Medwin Publ. 3 .
Kawai, T., and S. Akira, 2007 (1. November): Signaling to NF-κB by Toll-like receptors. Trends Mol. Med. 13 , 460–469, DOI: 10.1016/j.molmed.2007.09.002. Elsevier.
Krieg, A.M., A.K. Yi, S. Matson, T.J. Waldschmidt, G.A. Bishop, R. Teasdale, G.A. Koretzky, and D.M. Klinman, 1995: CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374 , 546–9, DOI: 10.1038/374546a0.
Kuwajima, S., T. Sato, K. Ishida, H. Tada, H. Tezuka, and T. Ohteki, 2006: Interleukin 15-dependent crosstalk between conventional and plasmacytoid dendritic cells is essential for CpG-induced immune activation. Nat. Immunol. 7 , 740–6, DOI: 10.1038/ni1348.
Langellotti, C.A., J.S. Pappalardo, V. Quattrocchi, C. Mongini, and P. Zamorano, 2011: Induction of specific cytotoxic activity for bovine herpesvirus-1 by DNA immunization with different adjuvants.Antiviral Res. 90 , 134–42, DOI: 10.1016/j.antiviral.2011.03.185.
Lee, S.H., S.N. Danishmalik, and J.I. Sin, 2015: DNA vaccines, electroporation and their applications in cancer treatment. Hum. Vaccines Immunother. 11 , 1889–1900, DOI: 10.1080/21645515.2015.1035502.
Lewis, P.J., van Drunen Littel-van den Hurk, and L.A. Babiuk, 1999: Altering the cellular location of an antigen expressed by a DNA-based vaccine modulates the immune response. J. Virol. 73 , 10214–23.
Ludewig, B., F. Barchiesi, M. Pericin, R.M. Zinkernagel, H. Hengartner, and R.A. Schwendener, 2000: In vivo antigen loading and activation of dendritic cells via a liposomal peptide vaccine mediates protective antiviral and anti-tumour immunity. Vaccine 19 , 23–32, DOI: 10.1016/S0264-410X(00)00163-8.
Manoj, S., P.J. Griebel, L.A. Babiuk, and S. van Drunen Littel-van den Hurk, 2004: Modulation of immune responses to bovine herpesvirus-1 in cattle by immunization with a DNA vaccine encoding glycoprotein D as a fusion protein with bovine CD154. Immunology 112 , 328–38, DOI: 10.1111/j.1365-2567.2004.01877.x.
Mars, M.H., M.C.M. De Jong, P. Franken, and J.T. Van Oirschot, 2001: Efficacy of a live glycoprotein E-negative bovine herpesvirus 1 vaccine in cattle in the field. Vaccine 19 , 1924–1930, DOI: 10.1016/S0264-410X(00)00435-7.
Miethke, A., G.M. Keil, F. Weiland, and T.C. Mettenleiter, 1995: Unidirectional complementation between glycoprotein B homologues of pseudorabies virus and bovine herpesvirus 1 is determined by the carboxy-terminal part of the molecule. J. Gen. Virol. 76 ( Pt 7) , 1623–35, DOI: 10.1099/0022-1317-76-7-1623.
Pappalardo, J.S., M.M. Chodilef, A.C. Mignaqui, R. Marcellino, A.L. Zamit, S. Salmaso, T.S. Levchenko, V.P. Torchilin, and C.A. Robles, 2016: Novel mannose-α(1→2)-mannose decorated liposomes for dendritic cell targeted nanovaccines: strong humoral and cell immune response against Brucella ovis. p. 33. In: Int. Congr. Immunol. Vol. 46, Suppl. 1 Aust. Melbourne: European Journal of Immunology.
Pappalardo, J.S., M. Toniutti, S. Salmaso, T.S. Levchenko, and V.P. Torchilin, 2013: Compounds and methods for targeted immune system delivery (Granted: 2018.05.08) United States Patent and Trademark Office (USPTO), ed. World Intellectual Property Organization (WIPO). United States of America.
Quattrocchi, V., I. Soria, C.A. Langellotti, V. Gnazzo, M. Gammella, D.P. Moore, and P.I. Zamorano, 2017: A DNA vaccine formulated with chemical adjuvant provides partial protection against bovine herpes virus infection in cattle. Front. Immunol. 8 , DOI: 10.3389/fimmu.2017.00037.
Rajčáni, J., T. Moško, and I. Režuchová, 2005: Current developments in viral DNA vaccines: shall they solve the unsolved? Rev. Med. Virol. 15 , 303–325, DOI: 10.1002/rmv.467.
Raz, E., H. Tighe, Y. Sato, M. Corr, J.A. Dudler, M. Roman, S.L. Swain, H.L. Spiegelberg, and D.A. Carson, 1996: Preferential induction of a Th1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization. Proc. Natl. Acad. Sci. U. S. A.93 , 5141–5145, DOI: 10.1073/pnas.93.10.5141.
Reed, L.J., and H. Muench, 1938: A simple method of estimating fifity percent endpoints. Am. J. Epidemiol. 27 , 493–497, DOI: 10.1093/oxfordjournals.aje.a118408.
Robles, C., 2009: Protocolo para la obtención del antígeno HS (Hot Saline Extract) de Brucella Ovis Cepa Reo 198 para el diagnóstico serológico de la brucelosis ovina. Comunicación Técnica EEA Bariloche Nro. 557. 2009., Bariloche.
Romera, S.A., L.A. Hilgers, M. Puntel, P.I. Zamorano, V.L. Alcon, M.J. Dus Santos, J. Blanco Viera, M. V Borca, and A.M. Sadir, 2000: Adjuvant effects of sulfolipo-cyclodextrin in a squalane-in-water and water-in-mineral oil emulsions for BHV-1 vaccines in cattle.Vaccine 19 , 132–41, DOI: 10.1016/s0264-410x(00)00104-3.
Romera, S.A., M. Puntel, V. Quattrocchi, P.D.M. Zajac, P. Zamorano, J. Blanco Viera, C. Carrillo, S. Chowdhury, M. V. Borca, and A.M. Sadir, 2014: Protection induced by a glycoprotein E-deleted bovine herpesvirus type 1 marker strain used either as an inactivated or live attenuated vaccine in cattle. BMC Vet. Res. 10 , 8, DOI: 10.1186/1746-6148-10-8.
Sin, J.I., J.J. Kim, R.L. Arnold, K.E. Shroff, D. McCallus, C. Pachuk, S.P. McElhiney, M.W. Wolf, S.J. Pompa-de Bruin, T.J. Higgins, R.B. Ciccarelli, and D.B. Weiner, 1999: IL-12 gene as a DNA vaccine adjuvant in a herpes mouse model: IL-12 enhances Th1-type CD4+ T cell-mediated protective immunity against herpes simplex virus-2 challenge. J. Immunol. 162 , 2912–21.
Suschak, J.J., J.A. Williams, and C.S. Schmaljohn, 2017 (2. December): Advancements in DNA vaccine vectors, non-mechanical delivery methods, and molecular adjuvants to increase immunogenicity. Hum. Vaccines Immunother. 13 , 2837–2848, DOI: 10.1080/21645515.2017.1330236. Taylor and Francis Inc.
Tikoo, S.K., M. Campos, and L.A. Babiuk, 1995: Bovine herpesvirus 1 (Bhv-1): Biology, Pathogenesis, and Control. Adv. Virus Res.45 , 191–223, DOI: 10.1016/S0065-3527(08)60061-5.
Van Drunen Littel-van den Hurk, R.P. Braun, P.J. Lewis, B.C. Karvonen, M.E. Baca-Estrada, M. Snider, D. McCartney, T. Watts, and L.A. Babiuk, 1998: Intradermal immunization with a bovine herpesvirus-1 DNA vaccine induces protective immunity in cattle. J. Gen. Virol. 79 ( Pt 4) , 831–9, DOI: 10.1099/0022-1317-79-4-831.
van Drunen Littel-van den Hurk, S., 2006: Rationale and perspectives on the success of vaccination against bovine herpesvirus-1. Vet. Microbiol. 113 , 275–82, DOI: 10.1016/j.vetmic.2005.11.002.
Vázquez, M.B., M. Sureda, and J. Rebollo, 2012 (1. January): Dendritic cells I: Basic biology and functions. Inmunologia 31 , 21–30, DOI: 10.1016/j.inmuno.2011.10.001. Elsevier Doyma.
Yamakawa, Y., C. Pennelegion, S. Willcocks, A. Stalker, N. MacHugh, D. Burt, T.J. Coffey, and D. Werling, 2008: Identification and functional characterization of a bovine orthologue to DC-SIGN. J. Leukoc. Biol. 83 , 1396–1403, DOI: 10.1189/jlb.0807523.
Yamamoto, S., T. Yamamoto, T. Kataoka, E. Kuramoto, O. Yano, and T. Tokunaga, 1992: Unique palindromic sequences in synthetic oligonucleotides are required to induce IFN [correction of INF] and augment IFN-mediated [correction of INF] natural killer activity.J. Immunol. 148 , 4072–6.
Zaman, M., M.F. Good, and I. Toth, 2013: Nanovaccines and their mode of action. Methods 60 , 226–31, DOI: 10.1016/j.ymeth.2013.04.014.
Zamorano, P., O. Taboga, M. Domínguez, S.A. Romera, M. Puntel, C. Tami, C. Mongini, C. Waldner, E. Palma, and A. Sadir, 2002: BHV-1 DNA vaccination: Effect of the adjuvant RN-205 on the modulation of the immune response in mice. Vaccine 20 , 2656–2664, DOI: 10.1016/S0264-410X(02)00211-6.
Zonouzi, A.A., A.P. Zonouzi, and M. Abkar, 2016: Recent Applications of DNA Vaccines in Cancer Therapy Vol. 2016Mol. Med. J. Kashan, Iran.